Fungal biofilm associated with long-term central venous access device: Complications and therapeutic difficulties
DOI:
https://doi.org/10.24265/horizmed.2018.v18n2.13Keywords:
Biofilm, Candidemia, Long-term central venous access catheterAbstract
Fungal infections associated with biofilms in biomedical devices are refractory to antifungal treatment and usually require the timely removal of the device, as well as the administration of systemic antifungals. We present the case of a 36-year- old female patient who received pain therapy administered by a Port-A-Cath long-term central venous access device. She developed catheter-related candidemi a and endocarditis caused by Candida parapsilosis. The catheter had to be removed by thoracotomy due to persistent infection despite the systemic antifungal therapy. An extensive biofilm surrounding the catheter was observed and Candida parapsilosis was isolated. Six weeks of antifungal treatment with a favorable clinical evolution were completed.
Downloads
References
Yousif A., Jamal M.A., Raad I. (2015) Biofilm-Based Central Line-Associated Bloodstream Infections. In: Donelli G. (eds) Biofilm-based Healthcare-associated Infections. Advances in Experimental Medicine and Biology, vol 830. Springer, Cham. DOI: 10.1007/978-3-319-11038-7_10.
Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo J, et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis. 2014 Feb;14(2):146-59.
Biffi R. (2012) History of Vascular Access. In: Di Carlo I., Biffi R. (eds) Totally Implantable Venous Access Devices. Springer, Milano. DOI: 10.1007/978-88-470-2373-4_1.
Pozo JL, Cantón E. Candidiasis asociada a biopelículas. Rev Iberoam Micol 2016; 33:176-83.
Bujdáková H. Management of Candida biofilms: state of knowledge and new options for prevention and eradication.. Future Microbiol. 2016;11(2):235-51.
Kojic EM, Darouiche RO. Candida Infections of Medical Devices. Clinical Microbiology Reviews. 2004;17(2):255-267.
Høiby et al. ESCMID Biofilm guideline. Clin Microbiol Infect 2015; 21: S1–S25.
Devrim I, et al. A Single Center’s Experience with Candida parapsilosis Related Long-Term Central Venous Access Device Infections: The Port Removal Decision and Its Outcomes. Pediatr Hematol Oncol. 2014;31(5):435-41.
Rodriguez L, Bustamante B, Huaroto L, Agurto C, Illescas R, Ramirez R, et al. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes. PLoS ONE 2017,12(4): e0175172.
Hirota K, Yumoto H, Sapaar B, Matsuo T, Ichikawa T, Miyake, Y. Pathogenic factors in Candida biofilm-related infectious diseases. J Appl Microbiol 2017;122: 321–330.
Nett J, Lincoln L, Marchillo K et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 2007;51(2), 510–520.
Fernández-Ruiz et al. Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis. Clinical Infectious Diseases 2014;58(10):1413–21
Pappas P, Kauffman C, Andes D, Clancy C, Marr K, Ostrosky- Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62 (4): e1- e50.
Cuenca-Estrella et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18(7): 9–18
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
